Disorders of continuity of bone

M13_BONECONTINUITY

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M84 Cause of death: ICD-10 — M84 2 out of 7 registries used, show all original rules.	3895
4. Check minimum number of events None	3895
5. Include endpoints None	3895
6. Filter based on genotype QC (FinnGen only)	3895

Control definitions (FinnGen only)

Control exclude: M13_OSTEOCHONDRO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M80-M85
Name in latin: Perturbationes continuitatis ossis

NAME	M13_BONECONTINUITY
CONTROL_EXCLUDE	M13_OSTEOCHONDRO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M84
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M84
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of continuity of bone based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	29414	15578	13687
Only index persons	27495	14661	12834
Unadjusted period prevalence (%)
Whole population	0.42	0.45	0.38
Only index persons	0.52	0.54	0.49
Median age at first event (years)
Whole population	48.36	55.08	40.68
Only index persons	47.21	54.33	39.07

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3895	2512	1383
Unadjusted period prevalence (%)	0.77	0.86	0.61
Median age at first event (years)	53.59	54.48	51.97

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3423: Matched controls
34229

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M84.0

ICD-10 Finland

Malunion of fracture

2958.0

323.0

742

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

14344.4

323.0

1026

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

307.7

323.0

1188

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

2935.1

294.9

281

X59

ICD-10 Finland

Exposure to unspecified factor

4.3

251.1

1137

3520

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.6

236.6

1446

5756

M84.2

ICD-10 Finland

Delayed union of fracture

1943.3

202.0

194

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

15.7

194.2

328

229

N02AX02

ATC

tramadol; systemic, rectal

2.9

179.0

1743

9105

X58

ICD-10 Finland

Exposure to other specified factors

3.8

160.2

798

2539

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.9

155.9

569

1344

M84.8

ICD-10 Finland

Other disorders of continuity of bone

372.6

144.0

144

M79.6

ICD-10 Finland

Pain in limb

2.6

141.5

1510

7963

NCK30

NOMESCO Finland

Angulation, rotation or displacement osteotomy of elbow or forearm, other location

107.5

141.3

154

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

5.9

140.5

422

791

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

6.1

132.5

386

694

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.4

132.4

1825

10916

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

4.8

121.9

440

1012

N03AX16

ATC

pregabalin; oral

2.7

116.1

1002

4552

N02AJ06

ATC

codeine and paracetamol; systemic

2.4

115.5

1517

8640

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

5.4

115.3

372

753

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.5

111.7

1221

6302

N02AA05

ATC

oxycodone; systemic

3.4

109.7

597

1978

ND1AA

NOMESCO Finland

Wrist X-ray examination

4.9

109.0

389

879

B01AB05

ATC

enoxaparin; parenteral

2.4

105.4

1150

5889

S52.5

ICD-10 Finland

Fracture of lower end of radius

3.7

103.8

515

1580

TQW40

NOMESCO Finland

Remowal of suture of skin

4.2

103.4

427

1114

N03AX12

ATC

gabapentin; oral

2.9

100.6

703

2767

ZXA00

NOMESCO Finland

Right side

2.5

100.0

1043

5187

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

5.1

98.8

333

704

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

9.1

98.1

215

251

N02BE01

ATC

paracetamol; systemic, rectal

2.7

97.2

2994

24611

M05BX04

ATC

denosumab; parenteral

6.7

95.1

255

406

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.5

93.3

493

1582

M25.5

ICD-10 Finland

Pain in joint

2.3

93.3

1168

6319

WX320

NOMESCO Finland

Spinalanesthesy

2.5

93.0

888

4184

NF3AA

NOMESCO Finland

Femur X-ray examination

11.6

92.0

176

159

M81.9

ICD-10 Finland

Osteoporosis, unspecified

12.3

91.8

171

146

NH1AD

NOMESCO Finland

Ankle and foot CT

8.9

91.4

202

239

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

23.6

91.2

132

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

51.1

90.3

109

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

5.6

89.2

278

536

S92.3

ICD-10 Finland

Fracture of metatarsal bone

5.8

87.6

264

488

ZXA05

NOMESCO Finland

Left side

2.3

85.5

951

4815

ZXD05

NOMESCO Finland

Urgent procedure

2.2

85.2

1174

6575

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

5.1

84.7

283

590

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

9.2

84.2

182

207

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.5

82.0

426

1341

NDJ86

NOMESCO Finland

Late fixation of fracture of hand or wrist to promote bone formation

68.9

81.8

NBJ86

NOMESCO Finland

Late operation of shoulder or upper arm to promote bone formation

170.0

79.4

S18

ICPC

Laceration/cut

2.0

79.4

1451

9092

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.1

78.9

493

1775

W00

ICD-10 Finland

Fall on same level involving ice and snow

3.0

78.0

507

1874

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.0

77.1

501

1849

M01AH05

ATC

etoricoxib; oral

2.0

76.6

2104

15342

M05BA04

ATC

alendronic acid; oral

4.2

76.5

312

796

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

27.5

75.2

104

M84.9

ICD-10 Finland

Disorder of continuity of bone, unspecified

+∞

74.2

NG4AA

NOMESCO Finland

Lower leg X-ray examination

5.9

74.0

218

391

NGU20

NOMESCO Finland

Removal of internal fixation device from knee or lower leg

8.6

72.7

163

197

L28

ICPC

Limited function/disability (L)

2.7

71.2

557

2301

NDK30

NOMESCO Finland

Osteotomi and rotation of a bone of hand or wrist

88.7

70.2

T92.2

ICD-10 Finland

Sequelae of fracture at wrist and hand level

14.2

69.8

121

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

69.5

625

2795

NGJ86

NOMESCO Finland

Late operation of fracture of lower leg to promote bone formation

87.6

69.2

L17

ICPC

Foot/toe symptom/complaint

2.1

68.8

944

5175

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.0

68.2

296

797

M77.4

ICD-10 Finland

Metatarsalgia

3.9

67.8

301

827

NF1AA

NOMESCO Finland

Hip X-ray examination

3.4

67.6

351

1097

A02BC02

ATC

pantoprazole; systemic

1.9

67.0

2175

16437

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

6.8

66.9

175

268

Z3226

NOMESCO Finland

Physiotherapist

2.3

65.7

714

3504

S42.2

ICD-10 Finland

Fracture of upper end of humerus

4.4

65.3

250

598

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.7

65.0

308

894

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

64.7

1398

9113

S42.3

ICD-10 Finland

Fracture of shaft of humerus

11.6

64.1

122

109

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.8

63.9

296

842

S72.3

ICD-10 Finland

Fracture of shaft of femur

16.1

63.9

105

R4110

NOMESCO Finland

Physiotherapy

2.1

63.8

947

5339

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

63.6

504

2086

S42.0

ICD-10 Finland

Fracture of clavicle

5.8

63.6

190

346

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

9.9

63.5

131

137

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

5.4

62.9

198

384

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.7

62.5

295

853

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

62.2

542

2368

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

62.0

339

1100

S82.2

ICD-10 Finland

Fracture of shaft of tibia

8.4

61.4

139

171

NBU20

NOMESCO Finland

Removal of internal fixation device from shoulder or upper arm

13.2

61.1

109

W19

ICD-10 Finland

Unspecified fall

2.9

59.9

399

1483

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

22.0

59.8

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

58.4

961

5608

J01FF01

ATC

clindamycin; systemic

2.0

58.1

968

5673

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

58.0

585

2750

M54.5

ICD-10 Finland

Low back pain

1.9

57.3

1173

7409

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

56.9

721

3768

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.8

56.8

404

1563

H02AB06

ATC

prednisolone; systemic

1.8

55.2

1554

10888

C03CA01

ATC

furosemide; systemic

2.1

55.1

765

4150

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

7.3

55.1

137

195

S82.3

ICD-10 Finland

Fracture of lower end of tibia

6.3

55.0

151

247

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.4

54.9

209

496

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

54.4

1223

7945

NB6AA

NOMESCO Finland

Humerus X-ray examination

7.0

54.3

138

203

J01DB01

ATC

cefalexin; oral

2.0

54.3

2779

23562

NHJ86

NOMESCO Finland

Late operation or reoperation of fracture of foot or toe

42.6

53.9

ZZH22

NOMESCO Finland

Graft of patients own bone, block

24.3

53.3

318

Kela drug reimbursment

Teriparatide

275.2

53.3

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

8.0

53.2

124

160

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.8

51.7

367

1415

ZZH20

NOMESCO Finland

Graft of patients own bone

21.6

51.5

H05AA02

ATC

teriparatide; parenteral

264.5

51.2

SPAT1153

SPAT

Removal of sutures

1.9

50.9

1052

6602

S62.0

ICD-10 Finland

Fracture of navicular [scaphoid] bone of hand

9.6

50.4

105

112

NBJ62

NOMESCO Finland

Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus

8.7

50.1

111

132

ND1AD

NOMESCO Finland

Wrist CT examination

11.8

50.1

L16

ICPC

Ankle symptom/complaint

2.5

50.1

422

1797

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.7

48.7

146

267

NGJ60

NOMESCO Finland

Internal fixation of fracture of knee or lower leg using intramedullary nail, other or unspecified

11.1

48.2

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

6.4

47.8

130

210

WX212

NOMESCO Finland

Femoral plexus blockade

7.7

47.7

114

153

N05CF01

ATC

zopiclone; oral

1.8

47.6

1047

6680

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.6

47.4

385

1604

S72.0

ICD-10 Finland

Fracture of neck of femur

5.4

47.3

148

285

WX203

NOMESCO Finland

Infraclavicular plexus blockade

5.5

47.2

146

277

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.0

46.6

155

320

T92.1

ICD-10 Finland

Sequelae of fracture of arm

15.9

45.7

L76

ICPC

Fracture: other

5.4

45.6

143

276

WX702

NOMESCO Finland

Supraglottic ventilation device

3.2

45.4

251

817

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

45.4

933

5802

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

45.0

1220

8283

T93.2

ICD-10 Finland

Sequelae of other fractures of lower limb

9.0

44.6

109

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

44.3

919

5723

NFJ86

NOMESCO Finland

Late operation for fracture of femur to promote bone formation

443.3

44.3

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

6.9

44.3

114

171

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

44.0

443

2058

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

5.6

44.0

132

242

Z3231

NOMESCO Finland

Registered nurse

1.8

43.8

904

5614

N06AX11

ATC

mirtazapine; oral

1.8

43.7

1085

7154

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

43.3

1400

9973

L95

ICPC

Osteoporosis

5.7

42.6

127

231

NCU20

NOMESCO Finland

Removal of internal fixation device from elbow or forearm

8.6

42.4

112

NH3BG

NOMESCO Finland

MRI of foot

15.1

42.4

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

5.8

42.1

123

218

L11

ICPC

Wrist symptom/complaint

2.6

41.9

340

1411

N06AX21

ATC

duloxetine; oral

2.3

41.9

427

1994

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

41.7

388

1731

M01AB05

ATC

diclofenac; systemic, rectal

1.6

41.6

2198

17833

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

3.3

41.5

218

682

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

5.8

41.4

121

215

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

9.0

41.4

101

AA1AD

NOMESCO Finland

CT of head and brain

1.9

40.1

720

4243

L74

ICPC

Fracture: hand/foot bone

5.8

39.9

117

209

Z04.3

ICD-10 Finland

Examination and observation following other accident

5.3

39.7

126

247

J01MA02

ATC

ciprofloxacin; systemic

1.7

39.3

1182

8187

TND33

NOMESCO Finland

Custom moulded brace or cast, wrist or hand

7.8

39.3

120

M01AE02

ATC

naproxen; oral, rectal

1.6

39.1

1908

15029

M89.0

ICD-10 Finland

Algoneurodystrophy

36.2

39.1

M03BX02

ATC

tizanidine; oral

1.6

39.1

2068

16634

NH3CG

NOMESCO Finland

Extensive MRI of foot

13.9

38.8

NG4AD

NOMESCO Finland

Lower leg CT

38.2

38.8

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

3.5

38.6

190

566

M48.0

ICD-10 Finland

Spinal stenosis

2.3

38.3

374

1706

R03AC02

ATC

salbutamol; inhalant

1.6

38.1

1734

13379

NGJ84

NOMESCO Finland

Refixation of fracture of lower leg

72.7

38.0

R4120

NOMESCO Finland

Occupational therapy

2.8

38.0

254

939

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

6.4

37.9

102

163

A28

ICPC

Limited function/disability NOS

2.2

37.7

404

1929

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

37.5

710

4253

NGJ70

NOMESCO Finland

External fixation of fracture of knee or lower leg, other or unspecified

16.5

37.2

A06AD11

ATC

lactulose; oral

2.2

37.1

409

1976

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

6.9

37.0

139

ZZA00

NOMESCO Finland

Split skin graft

4.8

36.8

127

273

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.3

36.6

141

339

L03

ICPC

Low back symptom/complaint

1.8

36.5

809

5091

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

12.4

36.4

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.7

36.0

271

1074

SPAT1216

SPAT

Assessment of functional ability

2.1

36.0

451

2305

S82.6

ICD-10 Finland

Fracture of lateral malleolus

2.8

35.9

249

941

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

186.9

35.8

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.8

35.8

122

259

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

4.5

35.8

130

295

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

35.6

591

3369

S72.2

ICD-10 Finland

Subtrochanteric fracture

14.5

35.4

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

3.5

35.2

172

509

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.8

34.9

243

919

L13

ICPC

Hip symptom/complaint

2.0

34.6

487

2605

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.4

34.5

129

301

WX110

NOMESCO Finland

Local anesthesy

1.6

34.5

2312

19403

ZZH31

NOMESCO Finland

Bone allograft, small pieces

10.5

34.5

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

34.4

1084

7540

NB1AD

NOMESCO Finland

Shoulder CT examination

6.2

34.3

154

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

34.2

276

1135

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

9.5

34.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

34.2

708

4350

L08

ICPC

Shoulder symptom/complaint

1.9

34.1

616

3613

NBJ53

NOMESCO Finland

Open reduction of fracture of shoulder or upper arm, clavicle

9.4

34.0

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

34.0

612

3588

N05BA01

ATC

diazepam; systemic, rectal

2.0

33.6

466

2476

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

33.5

3034

27563

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.9

33.4

113

238

N05AH04

ATC

quetiapine; oral

1.9

33.4

577

3329

NB3AA

NOMESCO Finland

Clavicle X-ray examination

6.6

33.1

135

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

33.0

444

2330

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

33.0

1698

13303

J01MA12

ATC

levofloxacin; systemic

1.9

33.0

551

3142

A46

ICD-10 Finland

Erysipelas

2.1

32.9

419

2150

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.8

32.8

146

400

N06AA09

ATC

amitriptyline; systemic

2.3

32.7

342

1608

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

13.5

32.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

32.6

432

2252

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

4.7

32.3

113

247

S72.1

ICD-10 Finland

Pertrochanteric fracture

6.6

32.2

129

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

32.2

449

2389

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

32.1

384

1918

W10

ICD-10 Finland

Fall on and from stairs and steps

3.0

32.0

195

677

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

31.8

559

3240

A02BC01

ATC

omeprazole; systemic

1.7

31.7

838

5525

S97

ICPC

Chronic ulcer skin

3.1

31.7

186

629

ZZH40

NOMESCO Finland

Substitute of bone

7.9

31.6

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

4.7

31.5

109

236

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

31.4

623

3761

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

31.3

571

3351

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

31.2

795

5182

S72.4

ICD-10 Finland

Fracture of lower end of femur

10.9

31.2

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

31.1

393

2005

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.6

31.1

248

1014

WX002

NOMESCO Finland

Sedation and analgesia

1.8

31.1

603

3612

W17

ICD-10 Finland

Other fall from one level to another

3.1

31.1

180

605

WX200

NOMESCO Finland

Interscalenous plexus blockade

4.7

31.0

108

235

R51.80

ICD-10 Finland

Headache

1.9

30.5

517

2957

SPAT1229

SPAT

Assessment of need for aid

2.5

30.3

258

1092

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.3

30.3

161

509

L15

ICPC

Knee symptom/complaint

1.8

30.1

661

4114

WX202

NOMESCO Finland

Supraclavicular plexus blockade

5.4

30.0

174

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

30.0

561

3317

M02AA07

ATC

piroxicam; topical

1.6

29.9

1102

7908

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

83.3

29.8

NF3AD

NOMESCO Finland

Femur CT

156.3

29.7

NGK30

NOMESCO Finland

Angulation, rotation or displacement osteotomy of knee or lower leg

10.2

29.6

R60.0

ICD-10 Finland

Localized oedema

2.2

29.6

335

1632

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

29.6

370

1882

NCK68

NOMESCO Finland

Shortening or lengthening osteotomy of elbow or forearm, other location

50.5

29.4

N05BA04

ATC

oxazepam; oral

1.7

29.2

793

5249

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

4.3

29.1

111

265

WX204

NOMESCO Finland

Axillary plexus blockaced

3.6

29.1

137

394

ND1AI

NOMESCO Finland

Cone beam CT of wrist

9.5

29.1

L75

ICPC

Fracture: femur

8.7

28.9

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

5.7

28.8

150

SPAT1301

SPAT

No procedures

1.6

28.7

971

6807

NDA30

NOMESCO Finland

Exploration of joint of wrist or hand, arthroscopic

7.7

28.7

NDG20

NOMESCO Finland

Fusion of wrist, partial

11.7

28.6

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.2

28.6

317

1530

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

28.6

302

1424

M05BA07

ATC

risedronic acid; oral

4.3

28.5

107

252

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

28.1

306

1462

ZXD35

NOMESCO Finland

Usual procedure

3.4

28.1

143

438

NHG20

NOMESCO Finland

Fusion of talocrural joint

10.7

28.0

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

283.7

27.8

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.2

27.7

152

492

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

27.6

1126

8242

L12

ICPC

Hand/finger symptom/complaint

1.9

27.6

476

2730

A02BC05

ATC

esomeprazole; systemic

1.5

27.6

1242

9303

J04AB02

ATC

rifampicin; systemic

6.7

27.5

108

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

8.2

27.5

R03BB04

ATC

tiotropium bromide; inhalant

2.3

27.5

280

1298

L14

ICPC

Leg/thigh symptom/complaint

2.4

27.4

246

1072

N05CF02

ATC

zolpidem; oral

1.8

27.3

585

3603

NHJ50

NOMESCO Finland

Open reduction of fracture of foot or toe

8.9

27.2

J01DA01

ATC

[U] cefalexin; systemic

1.5

27.1

2012

16770

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.8

27.0

116

309

A01

ICPC

Pain general/multiple sites

2.3

27.0

259

1167

N06AX16

ATC

venlafaxine; oral

1.8

27.0

488

2846

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

62.5

27.0

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

26.9

240

1042

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.4

26.6

131

391

M01AC06

ATC

meloxicam; systemic, rectal

1.5

26.6

1134

8371

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

26.6

419

2326

WX400

NOMESCO Finland

Inhalation anesthesy

2.8

26.6

178

658

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.0

26.5

174

NCJ62

NOMESCO Finland

Internal fixation of fracture of forearm using plate

4.0

26.5

108

275

NGU10

NOMESCO Finland

Removal of external fixation device from knee or lower leg

19.3

26.5

NDJ84

NOMESCO Finland

Refixation of fracture of hand or wrist

46.1

26.5

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

13.3

26.4

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

26.1

242

1070

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

+∞

26.1

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.4

26.0

242

1073

A02BC03

ATC

lansoprazole; oral

1.6

26.0

867

6029

WX704

NOMESCO Finland

Intubation

2.3

25.8

256

1169

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

25.8

362

1923

M01AH02

ATC

rofecoxib; oral

1.9

25.8

409

2275

SPAT1210

SPAT

Application of cast or individual aid

2.9

25.7

166

600

R50.9

ICD-10 Finland

Fever, unspecified

1.9

25.4

431

2453

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.9

25.3

105

272

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

25.3

427

2429

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.1

25.3

101

253

R06.0

ICD-10 Finland

Dyspnoea

1.6

25.2

713

4742

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

4.5

25.2

202

M05BB03

ATC

alendronic acid and colecalciferol; oral

4.8

25.2

180

S22.3

ICD-10 Finland

Fracture of rib

2.5

25.2

205

848

SPAT1263

SPAT

Sampling

1.5

25.1

1312

10096

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

25.0

460

2692

S92.5

ICD-10 Finland

Fracture of other toe

3.8

24.8

109

297

NC2AA

NOMESCO Finland

Forearm X-ray examination

5.2

24.8

153

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

3.3

24.7

127

392

NGJ62

NOMESCO Finland

Internal fixation of fracture of knee or lower leg using plate and screws, other or unspecified

6.2

24.6

110

NCJ86

NOMESCO Finland

Late operation to promote bone formation of fracture of forearm

130.9

24.6

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.7

24.4

110

306

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

24.4

372

2036

S82.1

ICD-10 Finland

Fracture of upper end of tibia

4.7

24.4

182

M13.9

ICD-10 Finland

Arthritis, unspecified

2.3

24.2

235

1064

ZXE00

NOMESCO Finland

One hour or less

1.5

24.1

1209

9198

J01FA06

ATC

roxithromycin; oral

1.5

24.1

1243

9514

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

4.6

24.0

185

Z71.8

ICD-10 Finland

Other specified counselling

1.6

24.0

748

5098

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

9.2

24.0

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.4

23.9

117

348

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

37.8

23.9

S52.6

ICD-10 Finland

Fracture of lower end of both ulna and radius

4.3

23.9

218

M19.2

ICD-10 Finland

Other secondary arthrosis

5.5

23.8

131

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

4.6

23.7

183

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

23.7

631

4124

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.9

23.4

145

508

Y94.8

ICD-10 Finland

Other leisure activity accident

3.3

23.4

120

370

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.5

23.3

113

334

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.7

23.3

167

644

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

23.2

330

1761

M81.8

ICD-10 Finland

Other osteoporosis

17.3

23.1

Z00.0

ICD-10 Finland

General medical examination

1.7

23.0

562

3581

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.6

23.0

176

704

M01AX17

ATC

nimesulide; oral

1.6

23.0

707

4792

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.6

23.0

176

705

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

22.9

691

4659

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

22.8

385

2186

M01AH01

ATC

celecoxib; oral (coxibs)

1.7

22.7

553

3521

S62.6

ICD-10 Finland

Fracture of other finger

2.7

22.7

164

636

NH1AI

NOMESCO Finland

Cone beam CT of ankle

11.5

22.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

22.6

2296

19981

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

22.6

1152

8761

NDK99

NOMESCO Finland

Other operation on bone of hand or wrist

23.1

22.6

R52.2

ICD-10 Finland

Other chronic pain

3.1

22.5

128

424

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

5.7

22.5

116

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.9

22.4

144

519

NHG22

NOMESCO Finland

Fusion of subtalar joint

8.7

22.3

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.3

22.2

212

952

J01AA02

ATC

doxycycline; systemic

1.5

22.1

2442

21552

NHK10

NOMESCO Finland

Incision or excision of metatarsal or tarsal bone

6.1

22.1

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

22.0

139

497

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

21.9

213

965

Z50.1

ICD-10 Finland

Other physical therapy

2.4

21.9

185

781

NCJ84

NOMESCO Finland

Refixation of fracture of forearm

62.9

21.8

NG1AD

NOMESCO Finland

Knee CT examination

5.6

21.8

116

ZXD20

NOMESCO Finland

Day surgery

1.8

21.8

420

2490

NBJ60

NOMESCO Finland

Internal fixation of fracture of shoulder or upper arm using intramedullary nail, humerus

22.3

21.7

SPAT1211

SPAT

Application of soft bandage

2.0

21.6

290

1511

Y96.9

ICD-10 Finland

Unspecified type of accident

4.1

21.5

207

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

21.4

914

6675

N05CD07

ATC

temazepam; oral

1.9

21.4

339

1879

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

21.4

1539

12486

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

5.2

21.3

132

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

17.5

21.3

ACC51

NOMESCO Finland

Release of median nerve

2.1

21.2

244

1194

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

11.6

21.2

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.0

21.2

276

1421

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

21.2

266

1352

WX402

NOMESCO Finland

General anaesthesia

1.7

21.0

519

3313

WZA90

NOMESCO Finland

Other doctors statement

1.6

20.9

728

5074

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

28.2

20.9

M05BA06

ATC

ibandronic acid; systemic

4.8

20.9

148

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.2

20.9

230

1104

TND32

NOMESCO Finland

Custom moulded splint, wrist or hand

5.0

20.8

136

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2192

14505

2.17

118.46

10.1

6.2

mmol/l

1.2

0.32

1887

12296

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2038

13114

2.16

118.35

8.6

5.6

mmol/l

1.2

0.25

1891

11891

(3042936) Bacteria identified in Isolate by Culture

863

4138

2.39

100.38

2.9

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1925

12902

1.97

91.50

2.9

2.2

nmol/l

77.9

76.3

1.58

1785

11775

(3023368) Bacteria identified in Blood by Culture

1257

7369

2.04

86.48

5.5

4.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1871

12665

1.92

83.86

6.6

4.7

g/l

35.3

36.1

6.72

1755

11819

(42870588) Differential panel, method unspecified - Blood

1615

10448

1.93

82.69

7.8

5.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

505

2071

2.65

80.68

4.2

3.7

ng/l

90.3

83.4

0.40

448

1819

(3013826) Glucose [Moles/volume] in Serum or Plasma

2381

17677

1.89

77.80

6.5

4.4

mmol/l

6.6

0.45

2262

16440

(3013115) Eosinophils [#/volume] in Blood

2235

16317

1.87

76.37

8.1

6.0

e9/l

0.2

0.04

2007

14396

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2979

23907

2.05

76.27

10.4

7.2

u/l

81.4

77.0

4.85

2872

22554

(3006315) Basophils [#/volume] in Blood

2171

15754

1.85

75.11

7.8

5.8

e9/l

0.0

1.00

1926

13661

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2034

14477

1.85

74.78

4.9

3.8

—

(3001604) Monocytes [#/volume] in Blood

2164

15702

1.85

74.74

7.8

5.8

e9/l

0.6

1.85

1917

13625

(3019198) Lymphocytes [#/volume] in Blood

2210

16203

1.84

73.14

7.8

5.8

e9/l

1.9

2.0

0.73

1977

14360

(3018418) pH of Serum or Plasma

1358

8556

1.90

73.13

6.2

3.7

7.4

1.03

253

1593

(3032080) INR in Blood by Coagulation assay

1673

11289

1.84

72.32

8.4

7.9

inr

1.2

0.34

446

3363

(3013707) Erythrocyte sedimentation rate by Westergren method

2918

23416

1.98

72.31

5.6

3.9

mm/h

13.4

11.1

12.40

2767

21797

(3003458) Phosphate [Moles/volume] in Serum or Plasma

718

3618

2.21

71.83

8.1

5.8

mmol/l

1.1

1.0

0.27

673

3378

(3019069) Monocytes/100 leukocytes in Blood

2051

14851

1.80

69.16

8.5

6.2

8.5

0.02

1935

13953

(3018010) Neutrophils/100 leukocytes in Blood

2079

15118

1.80

69.08

7.9

5.8

57.4

56.6

2.42

1944

14191

(3002030) Lymphocytes/100 leukocytes in Blood

2100

15333

1.80

68.66

8.2

6.0

27.9

28.9

4.15

1968

14343

(3006504) Eosinophils/100 leukocytes in Blood

2039

14759

1.80

68.64

8.2

5.9

2.8

0.21

1910

13787

(3007853) Bacteria identified in Skin by Aerobe culture

688

3483

2.18

67.68

2.2

1.7

—

(3022096) Basophils/100 leukocytes in Blood

1986

14309

1.79

67.47

8.3

6.0

0.7

0.24

1860

13389

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2135

15717

1.79

67.38

7.4

6.0

umol/l

10.1

11.1

4.76

2025

14879

(3013650) Neutrophils [#/volume] in Blood by Automated count

2379

18228

1.78

64.01

11.7

8.9

e9/l

4.1

4.0

2.33

2130

15942

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

808

4440

2.03

63.62

2.1

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

460

2048

2.41

60.96

3.4

2.5

g/l

66.4

66.7

0.30

420

1893

(3004588) Protein electrophoresis panel - Serum or Plasma

394

1646

2.55

59.85

3.3

2.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

20.22

57.38

1.9

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

1413

9600

1.74

55.63

2.9

2.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1318

8781

1.76

55.60

2.4

2.1

u/l

232.5

221.4

0.14

1253

8262

(3034860) Kappa light chains.free [Mass/volume] in Serum

218

690

3.29

55.14

4.1

3.3

mg/l

59.6

55.9

0.06

172

568

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

218

690

3.29

55.14

4.1

3.3

mg/l

47.3

48.3

0.02

176

570

(40760888) Immunoglobulin light chains.free panel - Serum

177

497

3.68

53.88

3.8

3.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1139

7347

1.78

53.31

2.6

2.1

mg/l

3.0

2.9

0.58

985

6298

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

590

3077

2.08

52.69

7.9

7.7

kpa

5.1

0.43

562

2947

(3022948) Iron [Moles/volume] in Serum or Plasma

772

4433

1.92

52.42

3.2

2.4

umol/l

12.7

13.7

3.27

715

4124

(3027801) Oxygen [Partial pressure] in Arterial blood

589

3077

2.08

52.34

7.9

7.7

kpa

12.4

12.8

0.98

561

2946

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

210

671

3.25

52.28

4.0

3.3

ratio

1.8

2.6

0.35

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

587

3066

2.08

52.18

1.9

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2646

21488

1.72

52.10

5.5

4.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

182

535

3.52

51.71

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

587

3080

2.07

51.49

2.0

1.7

—

(3003396) Base excess in Arterial blood by calculation

585

3068

2.07

51.38

8.0

7.7

mmol/l

1.3

1.0

0.73

473

2395

(3016502) Oxygen saturation in Arterial blood

536

2733

2.11

50.70

8.2

95.8

0.08

509

2641

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1642

11857

1.67

50.06

2.1

1.9

pmol/l

97.8

96.9

0.27

876

6074

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1375

9478

1.70

50.05

3.5

2.5

u/l

57.5

58.4

0.19

1276

8775

(3004789) Transferrin [Mass/volume] in Serum or Plasma

713

4084

1.91

48.39

3.2

2.4

g/l

2.4

0.46

674

3784

(3002173) Hemoglobin [Mass/volume] in Arterial blood

501

2552

2.11

47.33

8.6

g/l

117.6

122.7

6.55

477

2460

(3031040) Bacteria [#/volume] in Urine by Automated count

2505

20337

1.65

46.38

5.4

4.1

e6/l

886.3

1972.2

0.80

260

(3012095) Magnesium [Moles/volume] in Serum or Plasma

782

4671

1.84

46.35

3.9

3.5

mmol/l

0.8

3.27

724

4384

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

420

2020

2.21

45.88

1.7

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

661

3773

1.91

45.05

3.3

2.5

22.1

23.4

1.33

549

3247

(3037756) Immunofixation for Serum or Plasma

160

474

3.48

44.90

2.3

1.6

—

(3026008) Bacteria identified in Urine by Culture

1266

8734

1.67

44.79

3.6

2.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

132

344

3.94

44.70

9.9

6.8

mg/l

11.3

11.5

0.18

121

318

(3021960) Folate [Moles/volume] in Serum or Plasma

996

6456

1.73

44.42

1.6

1.5

nmol/l

20.7

20.9

0.14

884

5585

(3015377) Calcium [Moles/volume] in Serum or Plasma

1401

10006

1.62

42.72

4.3

3.3

mmol/l

2.4

0.59

1238

8877

(3027945) Reticulocytes/100 erythrocytes in Blood

532

2891

1.97

41.73

3.2

2.6

1.8

0.38

476

2598

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

544

3005

1.94

40.61

4.5

4.4

u/l

237.6

244.5

0.63

506

2856

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1074

7296

1.65

39.34

2.9

2.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1043

7040

1.66

39.15

2.0

1.8

mg/l

1.0

1.1

0.11

828

5279

(3019309) Folate [Moles/volume] in Red Blood Cells

780

4882

1.75

38.71

1.8

1.7

nmol/l

1206.0

1158.5

0.62

614

3705

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1091

7468

1.64

38.66

1.4

1.3

u/ml

1.5

1.7

0.38

255

1984

(3036481) Cortisol [Moles/volume] in Serum or Plasma

516

2866

1.92

37.72

2.2

2.1

nmol/l

355.6

379.9

1.79

471

2634

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3549

32396

2.08

36.99

22.3

12.2

mg/l

21.9

22.3

0.29

3018

25256

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

858

5574

1.69

36.97

4.0

3.4

ng/l

208.3

430.9

1.61

623

3992

(3033658) Prothrombin time (PT) actual/Normal

1118

7825

1.60

35.63

4.9

3.8

94.5

92.9

1.40

1087

7626

(3023520) Reticulocytes [#/volume] in Blood

404

2103

2.03

35.52

3.8

2.6

e9/l

71.4

71.0

0.09

318

1571

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

311

1465

2.22

35.49

9.2

10.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1803

14105

1.52

34.55

3.6

2.7

ug/l

123.2

112.4

1.04

1685

13184

(3019550) Sodium [Moles/volume] in Serum or Plasma

3555

32741

1.98

31.94

23.5

13.6

mmol/l

139.3

139.7

20.57

3500

31920

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

252

1140

2.29

31.64

1.7

1.8

g/l

1.5

0.17

217

999

(3000991) Gas panel - Venous blood

418

2289

1.93

31.62

10.0

8.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1046

7376

1.57

31.59

3.4

2.9

ng/l

1431.7

1149.2

1.24

906

6199

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1434

10833

1.51

31.58

4.3

3.2

ng/l

37.7

98.7

0.70

975

6740

(3014111) Lactate [Moles/volume] in Serum or Plasma

431

2413

1.88

30.43

8.7

7.2

mmol/l

1.3

0.52

415

2323

(3023103) Potassium [Moles/volume] in Serum or Plasma

3558

32866

1.95

30.35

23.8

13.7

mmol/l

4.0

3.39

3497

31979

(3026493) Urate [Moles/volume] in Serum or Plasma

1090

7826

1.55

30.12

3.0

2.4

umol/l

2193.5

4494.9

1.66

952

6892

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1396

10600

1.49

29.45

4.0

3.2

u/l

33.7

34.3

0.09

1323

10077

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

893

2.40

29.42

3.9

2.1

g/l

9.8

10.3

0.82

169

781

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

219

964

2.35

29.28

3.9

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

219

964

2.35

29.28

3.9

2.1

g/l

7.4

0.01

165

756

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

218

964

2.34

28.84

4.0

2.1

g/l

3.7

3.8

0.36

157

718

(3018677) aPTT in Platelet poor plasma by Coagulation assay

672

4348

1.66

28.59

2.2

29.2

29.6

1.44

656

4213

(3019060) Gas panel - Arterial blood

329

1719

2.00

28.44

5.5

5.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

933

6555

1.56

28.10

1.7

1.4

g/l

2.4

2.3

0.35

556

4083

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

916

2.34

27.77

4.0

2.1

g/l

3.0

3.1

0.28

159

739

(3035350) Ketones [Presence] in Urine by Test strip

1886

15303

1.45

27.76

4.4

3.4

estimate

0.0

0.80

357

2795

(3008152) Bicarbonate [Moles/volume] in Arterial blood

319

1665

2.00

27.64

7.4

mmol/l

25.1

24.5

1.96

296

1554

(3009261) Glucose [Presence] in Urine by Test strip

1906

15519

1.45

27.40

4.4

3.4

estimate

0.0

0.18

357

2773

(3005719) IgG [Mass/volume] in Serum or Plasma

415

2373

1.84

27.29

3.8

2.7

g/l

10.0

10.4

1.23

384

2173

(3047181) Lactate [Moles/volume] in Blood

198

863

2.36

27.07

6.3

7.1

mmol/l

1.2

1.3

0.41

175

754

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

279

1407

2.06

26.58

9.8

mmol/l

24.3

0.14

264

1329

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

192

833

2.37

26.52

3.4

2.1

g/l

0.9

0.8

0.15

169

743

(3000475) Leukocytes [#/volume] in Synovial fluid

165

671

2.52

26.24

1.7

e6/l

12644.1

12538.7

0.01

115

493

(3021601) Nitrite [Presence] in Urine by Test strip

1879

15355

1.43

25.92

5.8

4.6

estimate

0.0

0.33

361

2857

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

463

2778

1.76

25.84

2.4

2.3

g/l

0.2

0.35

421

2613

(3022217) INR in Platelet poor plasma by Coagulation assay

537

3360

1.69

25.76

21.0

21.1

inr

1.3

0.17

498

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

380

2152

1.85

25.72

2.8

ng/l

191.6

167.4

0.16

340

1935

(3030467) Casts [#/volume] in Urine by Automated count

1098

8130

1.49

25.39

3.5

2.9

e6/l

0.4

0.00

859

6028

(3002582) Erythrocytes [#/volume] in Urine

1180

8867

1.47

25.32

3.7

3.0

e6/l

46.2

81.5

1.01

930

6708

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

204

936

2.24

24.73

2.2

2.4

ug/l

311.3

737.7

1.14

187

881

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

299

1593

1.95

24.37

1.7

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

540

3437

1.66

24.18

8.6

7.0

mmol/l

103.9

104.6

2.26

530

3370

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

170

729

2.39

24.11

1.5

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

316

1723

1.91

24.03

9.8

9.3

93.7

94.1

0.50

316

1714

(3015736) pH of Urine

1499

11872

1.43

23.98

3.8

3.2

—

5.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3259

29768

1.58

23.87

5.3

4.7

mu/l

3.2

2.1

0.58

3066

27614

(3028026) IgM [Mass/volume] in Serum or Plasma

333

1857

1.87

23.61

2.3

1.8

g/l

1.3

1.4

0.11

298

1711

(3009508) Creatinine [Moles/volume] in Urine

1212

9258

1.45

23.50

4.1

3.2

mmol/l

7.3

7.7

1.82

1047

7874

(3039000) Anion gap in Blood

148

603

2.51

23.46

7.2

8.7

mmol/l

10.8

11.3

0.98

131

543

(3018572) Chloride [Moles/volume] in Blood

148

604

2.51

23.38

7.2

8.7

mmol/l

103.8

105.4

2.54

131

544

(36660697) Celiac disease serology panel - Serum

443

2697

1.73

23.38

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

173

766

2.32

22.82

3.0

2.0

g/l

38.0

37.7

0.19

151

682

(36304419) Bacteria [Presence] in Urine

1068

8005

1.46

22.74

3.5

2.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2834

25234

1.45

22.66

4.3

4.0

pmol/l

14.6

14.7

0.96

2615

23186

(3000850) Epithelial cells [#/volume] in Urine

851

6106

1.50

22.54

2.9

2.4

e6/l

5.7

6.4

0.77

765

5315

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

800

5682

1.51

22.20

1.3

iu/ml

31.0

29.3

0.12

250

1792

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

746

5225

1.53

22.10

3.4

2.9

mmol/l

2.5

2.4

0.95

656

4592

(40761511) CBC panel - Blood by Automated count

3612

34008

1.85

22.10

19.9

11.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

254

1325

1.98

21.98

1.1

u/ml

2.6

0.8

—

(40758558) Short blood count panel - Blood

1058

7959

1.45

21.96

9.2

6.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

411

2493

1.73

21.92

6.1

3.8

kpa

5.9

0.54

399

2418

(3007930) Methemoglobin/Hemoglobin.total in Blood

215

1059

2.09

21.79

6.4

6.2

0.9

0.23

197

992

(3020779) Urea [Moles/volume] in Serum or Plasma

402

2429

1.73

21.74

11.6

7.7

mmol/l

10.2

9.0

1.97

386

2335

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

168

751

2.29

21.68

3.1

2.0

g/l

0.0

1.17

155

701

(3037522) Nuclear Ab [Titer] in Serum

656

4484

1.56

21.67

1.4

titre

529.6

533.5

0.02

142

917

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

133

4.26

21.59

1.9

1.6

nmol/l

2.4

2.1

0.17

(3002032) Base excess in Venous blood by calculation

408

2481

1.72

21.56

6.1

3.8

mmol/l

2.3

1.9

1.65

344

2012

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

179

824

2.23

21.54

2.5

2.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

764

5406

1.51

21.51

1.3

u/ml

20.4

9.9

1.91

264

2179

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

292

1608

1.88

21.50

1.7

1.4

—

(3018095) Leukocytes [#/volume] in Urine

1343

10600

1.41

21.20

4.4

3.4

e6/l

89.2

96.2

0.12

985

7266

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

544

3578

1.60

21.18

3.0

2.7

umol/l

6.7

7.6

0.63

466

3099

(3012544) pH of Venous blood

418

2571

1.70

21.17

6.0

3.7

7.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

604

4089

1.56

20.75

1.9

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2532

22244

1.40

20.67

3.9

3.0

u/l

56.5

44.6

8.72

2406

20950

(3026782) Osmolality of Urine

788

5653

1.49

20.66

3.2

2.6

mosm/kgh2o

523.1

545.3

2.00

686

4814

(3021788) Differential panel - Synovial fluid

125

506

2.52

20.12

1.7

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

211

1068

2.03

19.87

6.5

6.0

1.9

1.6

2.04

193

998

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3634

34418

1.83

19.81

23.6

14.0

umol/l

76.5

74.2

2.41

3634

34407

(3003181) Sodium [Moles/volume] in Urine

111

433

2.61

19.30

1.5

1.4

mmol/l

60.9

63.4

0.22

354

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

153

698

2.24

18.84

3.2

2.0

g/l

0.0

0.00

140

651

(3017704) Immunofixation for Urine

131

4.01

18.58

2.3

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

169

812

2.13

18.30

2.3

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

336

2.78

18.20

1.7

1.5

51.5

56.6

0.58

212

(3019225) pH of Specimen

440

2849

1.61

18.13

6.2

3.9

—

(3044941) Cell count panel - Synovial fluid

110

441

2.54

18.10

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

941

7158

1.41

17.73

4.1

3.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

157

744

2.16

17.62

1.4

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

684

4913

1.48

17.52

2.9

2.5

e6/l

1.2

1.1

0.33

384

2695

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

148

693

2.18

17.12

3.3

2.1

g/l

0.0

0.00

139

650

(3019150) Specific gravity of Urine by Refractometry

880

6660

1.42

16.96

4.8

3.8

kg/l

1.0

0.01

146

962

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

191

990

1.98

16.85

2.5

2.0

ug/l

2.3

2.0

0.27

171

893

(4010399)

337

2077

1.68

16.84

1.5

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

609

4306

1.49

16.82

1.9

1.8

1.5

1.4

3.72

543

3850

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

355

2225

1.66

16.62

2.4

2.3

ug/l

9.3

7.3

0.30

297

1979

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

142

663

2.18

16.56

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

107

446

2.44

16.24

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

642

4622

1.47

16.14

3.2

2.7

e6/l

3.5

3.0

0.45

337

2414

(40768797) Stomach Pathology biopsy report

601

4276

1.48

16.04

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

330

2049

1.67

16.02

4.9

3.2

kpa

5.0

4.6

1.59

321

1981

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

141

672

2.14

15.63

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

263

2.85

15.45

1.4

1.6

promille

1.4

1.2

0.24

202

(3044889) 12 lead EKG panel

2447

21870

1.32

14.91

4.1

3.4

—

(3044927) Protein electrophoresis panel - Urine

239

2.88

14.51

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

606

2.15

14.45

6.9

5.5

iu/ml

678.7

350.7

0.33

(3023183) Ammonium ion [Moles/volume] in Plasma

128

608

2.14

14.33

3.8

2.9

umol/l

33.3

35.5

0.39

110

533

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

233

1359

1.76

14.20

6.2

4.1

mmol/l

24.7

24.2

1.68

217

1237

(3021879) Hepatitis B virus core Ab [Presence] in Serum

396

2644

1.55

14.20

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

135

657

2.09

14.20

1.7

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

168

892

1.92

13.85

1.4

ug/g

263.5

290.6

0.90

103

488

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

297

2.62

13.79

1.2

1.1

u/l

67.7

54.8

0.96

210

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3615

34585

1.63

13.74

14.2

9.7

u/l

27.5

26.7

0.92

3536

33503

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

724

5473

1.40

13.70

1.8

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

332

2146

1.60

13.69

1.4

1.3

u/ml

165.5

203.8

0.71

301

1986

(3009343) pH of Capillary blood

274

1691

1.67

13.60

4.4

3.5

7.4

0.16

205

(3021589) Normoblasts [#/volume] in Blood

1656

14154

1.30

13.53

13.3

8.7

e9/l

0.0

0.29

1383

11561

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

276

1715

1.66

13.34

4.4

3.5

kpa

5.2

0.32

254

1601

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

112

525

2.17

13.00

3.9

2.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

158

841

1.92

12.95

2.9

3.5

u/ml

0.4

0.14

484

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

430

2980

1.50

12.93

4.7

3.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2510

22707

1.30

12.91

3.4

3.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

238

2.76

12.90

2.8

2.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

121

587

2.10

12.87

1.4

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1409

11848

1.30

12.84

4.7

3.5

—

(3048689) Calprotectin [Mass/mass] in Stool

571

4187

1.43

12.80

2.1

2.4

ug/g

113.7

124.1

0.38

454

3343

(3002179) Metamyelocytes/100 leukocytes in Blood

349

2319

1.55

12.76

5.2

3.9

0.8

0.6

0.68

100

485

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

198

1145

1.77

12.45

2.1

1.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

206

1213

1.74

12.17

1.7

1.5

u/ml

15.4

13.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

264

2.60

12.07

1.2

1.4

e6/l

120709.7

103026.1

0.07

185

(3000093) Morphology [Interpretation] in Blood Narrative

242

2.67

11.97

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

844

6663

1.34

11.96

2.0

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

259

1632

1.63

11.86

4.5

3.4

mmol/l

2.0

1.7

0.73

192

1220

(3012516) Albumin [Mass/volume] in Urine

1028

8362

1.31

11.79

3.8

3.3

mg/l

770.8

312.4

1.63

682

5185

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

169

950

1.81

11.70

2.1

1.6

g/l

0.2

0.45

161

893

(3023419) Bacteria identified in Sputum by Culture

337

2.37

11.51

3.2

2.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

174

993

1.79

11.47

2.1

1.6

g/l

1.2

0.13

167

935

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

172

980

1.79

11.40

1.8

1.6

titre

128.5

491.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

174

996

1.78

11.35

2.0

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

180

1042

1.76

11.30

2.0

1.8

—

(3017181) Myelocytes/100 leukocytes in Blood

368

2539

1.50

11.28

5.6

4.1

1.0

0.9

0.36

116

667

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

117

590

2.01

11.25

4.3

3.6

58.6

56.0

1.10

117

590

(1761868) Lipid panel - Serum or Plasma

1028

12365

0.77

11.14

2.6

—

(3000494) Fungus identified in Specimen by Culture

507

3726

1.41

11.14

1.8

1.4

—

(3037121) Protein [Mass/volume] in Urine

171

980

1.78

11.12

3.1

3.2

g/l

0.4

0.3

0.61

410

(3017732) Neutrophils [#/volume] in Blood

327

2209

1.52

11.08

3.1

2.7

e9/l

4.1

0.16

242

1800

(3013512) EKG study

1016

8310

1.30

11.07

4.5

3.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

383

2.25

10.93

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

385

2.23

10.80

1.5

—

(3025159) Blasts/100 leukocytes in Blood

335

2288

1.51

10.78

5.8

4.2

0.0

0.4

0.90

103

522

(3008295) Osmolality of Serum or Plasma

293

2.41

10.66

1.7

1.5

mosm/kgh2o

280.5

281.2

0.09

236

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

466

2.11

10.64

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

205

1254

1.67

10.56

1.3

u/ml

0.3

1.1

1.78

109

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

176

1033

1.74

10.55

1.7

1.6

iu/ml

1.0

6.1

0.40

203

(3028707) Methadone [Presence] in Urine by Screen method

127

675

1.91

10.52

6.7

2.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

391

2.20

10.42

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1061

8788

1.28

10.37

4.4

4.0

mg/mmol

12.9

8.4

1.23

698

5498

(3009542) Hematocrit [Volume Fraction] of Blood

3225

30478

1.34

10.35

21.9

13.2

39.3

40.2

7.05

2309

23221

(3007461) Platelets [#/volume] in Blood

3749

36447

1.76

10.33

31.3

18.2

e9/l

260.0

255.8

3.66

3692

35586

(3004119) Hemoglobin [Mass/volume] in Venous blood

249

1608

1.59

10.32

4.9

3.2

g/l

124.7

130.0

3.13

243

1568

(3042111) Morphology [Interpretation] in Bone marrow Narrative

419

2.15

10.30

1.5

1.7

—

(3024731) MCV [Entitic volume]

3751

36475

1.77

10.28

31.1

18.1

91.1

90.6

9.17

3721

36026

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

774

6158

1.32

10.21

1.6

pmol/l

88739180.7

37127331.7

0.79

666

5193

(3026361) Erythrocytes [#/volume] in Blood

3751

36483

1.76

10.16

31.2

18.1

e12/l

4.4

4.5

46.04

3691

35539

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

344

2.26

10.13

1.5

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

114

592

1.95

10.13

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

114

592

1.95

10.13

1.3

—

(3035941) MCH [Entitic mass]

3750

36477

1.75

10.07

31.0

18.1

30.3

30.2

2.30

3720

36025

(3010813) Leukocytes [#/volume] in Blood

3751

36492

1.75

10.03

31.3

18.2

e9/l

6.9

6.6

6.74

3691

35546

(3000963) Hemoglobin [Mass/volume] in Blood

3751

36496

1.75

9.97

31.4

18.2

g/l

132.5

136.2

42.67

3721

36040

(40761535) Cells panel - Urine sediment

340

2367

1.48

9.96

4.2

3.3

—

(3002385) Erythrocyte distribution width [Ratio]

2933

27407

1.28

9.93

25.3

15.0

13.9

13.6

14.37

2899

26820

(3021440) Promyelocytes/100 leukocytes in Blood

346

2420

1.47

9.90

5.8

4.2

0.0

0.2

1.96

111

614

(3009214) Lutropin [Units/volume] in Serum or Plasma

163

955

1.74

9.85

1.6

1.4

u/l

9.8

10.4

0.20

131

779

(1001926) Buprenorphine [Presence] in Urine by Screen method

198

1225

1.65

9.78

5.2

2.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

382

2.17

9.76

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

476

2.04

9.72

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

142

2.98

9.71

1.9

2.9

umol/l

57.9

177.8

2.92

(3052851) Hemolysis interference index of Serum or Plasma

150

862

1.77

9.70

3.3

3.0

—

(3011288) Drugs identified in Urine by Screen method

176

1058

1.69

9.70

5.7

3.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

384

2.16

9.64

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

143

2.96

9.60

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

385

2.15

9.58

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

412

2.11

9.55

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

486

3637

1.38

9.55

4.2

4.3

33.1

32.2

0.99

363

2540

(3029937) Albumin [Presence] in Urine by Test strip

978

8116

1.27

9.24

5.3

3.7

estimate

0.0

1.74

355

2786

(3017446) Testosterone [Moles/volume] in Serum or Plasma

308

2137

1.48

9.18

2.5

2.2

nmol/l

11.8

12.9

1.41

276

1911

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

328

2308

1.46

9.10

6.0

3.4

mmol/l

1.2

0.29

297

2003

(1616796) Gas panel - Central venous blood

109

579

1.91

9.09

4.8

3.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

148

2.86

9.05

1.7

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

405

2981

1.40

8.76

3.9

2.4

u/l

38.4

54.9

0.51

324

2577

(3041096) Erythrocytes [Presence] in Urine by Automated

1013

8507

1.26

8.56

4.0

3.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

192

1220

1.60

8.55

4.6

2.8

0.6

0.7

0.08

185

1166

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

153

918

1.69

8.53

2.5

2.7

g/l

3.8

3.6

1.19

144

875

(4198724)

170

2.67

8.53

7.9

1.9

—

(3004809) Band form neutrophils/100 leukocytes in Blood

438

2.01

8.50

3.4

3.3

0.9

1.3

0.92

351

(3026389) Candida sp identified in Specimen by Organism specific culture

446

2.00

8.44

1.8

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

879

7270

1.27

8.43

5.6

4.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

183

2.59

8.40

1.1

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

190

1211

1.60

8.36

5.6

3.3

mmol/l

25.4

25.3

0.11

183

1170

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

133

2.88

8.31

1.2

1.1

u/l

21.9

19.2

0.18

104

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

133

2.88

8.31

1.2

1.1

u/l

117.3

80.3

0.51

106

(3016879) Cocaine [Presence] in Urine

220

1454

1.54

8.28

4.9

2.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.52

8.23

1.4

1.1

g/l

39.4

37.8

0.30

(3045414) Leukocytes [Presence] in Urine

214

1408

1.55

8.22

2.1

1.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

118

665

1.80

8.21

3.3

3.0

mmol/l

25.3

24.7

0.68

103

577

(3017354) Segmented neutrophils/100 leukocytes in Blood

271

2.27

8.21

3.8

3.3

61.3

57.3

0.73

188

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

284

2.24

8.19

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

168

2.64

8.18

2.8

2.7

46.8

41.2

0.59

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3059

28944

1.26

8.09

6.2

5.2

mmol/mol

39.8

39.2

2.67

2869

27045

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

175

2.59

8.08

1.6

u/l

7.0

5.7

0.21

(3028300) Cannabinoids [Presence] in Urine

234

1578

1.51

8.03

4.7

2.1

—

(3011985) Renin [Units/volume] in Plasma

393

2.03

8.00

1.8

1.4

mu/l

85.2

50.0

0.58

348

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

256

2.28

7.93

1.7

1.4

27.7

35.3

1.11

159

(3047189) Immunofixation for 24 hour Urine

110

3.02

7.88

2.2

1.7

—

(3027008) Opiates [Presence] in Urine

232

1573

1.50

7.77

3.8

2.1

—

(4062490)

324

2.12

7.73

1.5

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

333

2422

1.41

7.72

3.3

2.6

ml/min/173m2

63.2

69.4

1.93

145

916

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

272

2.22

7.72

2.7

2.8

—

(3000764) Benzodiazepines [Presence] in Urine

230

1567

1.50

7.53

4.7

2.1

—

(3022313) Gas panel - Capillary blood

191

1252

1.55

7.48

4.6

3.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

356

2.04

7.44

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

363

2.03

7.43

1.8

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

105

590

1.80

7.41

2.5

2.2

g/l

126.0

132.4

1.70

438

(3042517) Benzodiazepines panel - Urine

4.61

7.40

2.6

2.9

—

(44790048)

332

2.07

7.28

1.3

1.5

—

(44790047)

332

2.07

7.28

1.3

1.5

—

(44790049)

332

2.07

7.28

1.3

1.5

—

(44806118)

332

2.07

7.28

1.3

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

117

683

1.74

7.26

1.8

1.5

—

(3042733) HLA Ab [Presence] in Serum

100

3.02

7.18

6.2

5.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.02

7.18

20.9

9.2

mmol/l

5.1

6.0

0.57

(3019977) pH of Arterial blood

133

2.72

7.17

3.2

3.1

7.4

0.96

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

192

2.41

7.17

1.7

1.6

—

(3036603) Volume of Urine

186

2.44

7.16

1.7

1.4

2283.5

2076.2

—

(3025315) Body weight

6.89

7.15

4.0

5.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

181

2.45

7.08

1.2

1.1

u/l

78.8

82.4

0.14

159

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

370

1.99

7.07

1.4

pmol/l

297.8

300.1

0.02

287

(3024928) Oxygen saturation in Venous blood

104

592

1.78

7.05

4.5

3.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

116

682

1.72

7.03

1.2

—

14.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

149

938

1.61

6.96

1.3

1.2

u/ml

32.3

50.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

177

2.45

6.91

1.2

1.1

u/l

21.2

22.7

0.08

152

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3184

30417

1.26

6.85

18.5

11.2

ml/min/173m2

85.3

84.8

0.55

2726

24944

(3025941) Bacteria identified in Stool by Culture

259

1843

1.43

6.81

1.3

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

321

2.04

6.77

1.5

1.3

g/l

6.6

6.8

0.13

219

(3028192) IgG subclass 2 [Mass/volume] in Serum

321

2.04

6.77

1.5

1.3

g/l

3.1

2.9

0.31

220

(3024139) IgG subclass 3 [Mass/volume] in Serum

321

2.04

6.77

1.5

1.3

g/l

0.4

0.08

219

(3012501) Base excess in Blood by calculation

105

610

1.74

6.66

6.3

3.9

mmol/l

2.8

2.6

0.30

407

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

237

2.21

6.65

1.3

u/ml

0.4

0.5

0.10

102

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

148

942

1.59

6.62

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

139

873

1.61

6.57

1.3

u/ml

22.8

8.8

0.66

144

(3014765) Yersinia sp identified in Stool by Organism specific culture

149

953

1.59

6.54

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

219

1522

1.47

6.53

2.4

2.3

—

(40767503) Oxygen content in Capillary blood by calculation

569

1.76

6.52

3.2

2.4

16.1

16.8

0.97

280

(3027944) Amphetamines [Presence] in Urine

222

1550

1.46

6.47

4.5

2.1

—

(3014271) Vancomycin [Susceptibility]

107

2.82

6.41

3.4

2.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

107

633

1.71

6.38

1.8

1.4

u/ml

147.0

114.7

0.39

120

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

149

961

1.57

6.32

1.1

u/ml

15.8

4.3

0.71

134

(3020891) Body temperature

164

1083

1.54

6.27

6.5

4.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

161

2.44

6.26

2.5

2.6

u/ml

952.1

1105.6

0.19

161

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

130

814

1.62

6.24

4.1

3.9

mg/l

1.7

1.4

2.42

117

764

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.42

6.23

3.8

2.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

165

1094

1.53

6.20

5.1

3.7

mmol/l

24.9

0.01

154

1024

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.67

6.19

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

452

3566

1.30

6.18

9.2

6.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

166

1105

1.52

6.13

1.8

1.7

—

(3010421) pH of Blood

119

733

1.64

6.11

6.4

3.9

7.4

0.49

103

602

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

145

2.50

6.10

1.7

1.6

iu/ml

116619.0

1075877.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

112

680

1.67

6.08

1.2

u/ml

1.6

3.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

523

1.76

6.03

1.4

1.6

g/l

0.6

0.7

0.97

394

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.16

6.01

1.4

49.2

30.8

1.29

(42529406) Shigella sp [Presence] in Stool by Culture

147

960

1.55

5.93

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

511

1.76

5.92

1.4

u/l

22.8

27.0

0.59

418

(3022621) pH of Urine by Test strip

271

1994

1.39

5.91

3.7

2.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

134

859

1.58

5.86

1.3

1.2

u/ml

3.3

6.0

0.34

(40768804) Tissue Pathology biopsy report

1447

12975

1.18

5.83

2.2

2.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

140

908

1.56

5.82

3.0

2.6

187.2

182.7

0.23

129

870

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

364

1.88

5.69

1.4

1.5

—

(3024471) HLA-A [Type]

103

2.73

5.68

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

108

662

1.65

5.68

1.6

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

316

1.95

5.63

4.5

3.9

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

5.89

5.62

1.1

1.2

ml/s/173m2

0.7

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

235

2.10

5.58

1.4

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

140

918

1.54

5.57

1.1

1.3

titre

78.0

161.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.85

5.50

1.8

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

258

3438

0.73

5.46

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

540

1.70

5.42

1.8

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

495

4022

1.26

5.35

2.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

162

2328

0.68

5.35

1.4

—

(3008898) HLA-B27 [Presence]

184

1295

1.44

5.20

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.14

5.18

1.8

2.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

149

1007

1.50

5.17

2.4

2.3

97.1

92.9

1.41

135

942

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

112

712

1.59

5.12

1.2

u/ml

36.8

38.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

335

1.86

5.08

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

159

1099

1.47

4.95

1.6

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

140

944

1.50

4.93

1.9

1.8

nmol/l

41.6

38.9

0.66

135

917

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

442

1.73

4.90

1.2

1.3

nmol/l

0.6

0.02

427

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

115

744

1.56

4.90

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

304

1.89

4.87

2.8

2.2

mg/l

24.3

24.6

0.02

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

221

2.05

4.86

2.4

2.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

235

2.01

4.84

2.1

2.0

14.0

11.4

0.63

106

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

175

2.18

4.83

1.7

2.4

108.8

97.3

0.73

166

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

125

827

1.53

4.82

2.4

2.0

mg/l

10.7

11.2

0.28

114

772

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

186

1333

1.42

4.78

2.3

1.9

u/l

42.3

39.4

1.08

167

1205

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

113

2.49

4.78

1.8

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

113

2.49

4.78

1.8

1.4

—

(3011412) CD3 cells [#/volume] in Blood

299

1.89

4.78

2.8

2.5

e9/l

1.2

0.04

174

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

217

2.04

4.71

3.5

2.7

e6/l

797.5

741.3

0.18

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

537

4467

1.23

4.71

2.1

—

(3022145) Colonoscopy Study observation

432

3509

1.26

4.69

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

238

1.99

4.68

2.1

2.0

76.0

72.7

1.05

231

(3000060) B lymphocytes [#/volume] in Blood

2.72

4.67

2.3

1.9

e6/l

196.9

186.2

0.04

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

960

8444

1.18

4.66

1.7

1.6

mmol/l

1.4

0.38

842

7188

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

218

2.03

4.66

1.2

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3202

30897

1.20

4.64

4.6

4.2

mmol/l

6.0

5.9

5.00

2963

28510

(3024932) HLA-DR beta [Type]

103

2.53

4.62

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

444

1.70

4.57

1.2

1.3

nmol/l

0.5

0.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

104

2.51

4.54

1.2

1.1

100.2

87.4

0.96

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

394

1.74

4.48

1.2

1.3

nmol/l

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

271

1.89

4.44

1.9

2.2

nmol/l

18.0

20.1

1.03

258

(3011648) Oxygen content in Venous blood

236

1.96

4.44

4.6

2.7

11.2

0.00

236

(3014051) Protein [Presence] in Urine by Test strip

110

722

1.54

4.43

2.5

2.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

246

1.92

4.29

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

246

1.92

4.29

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

246

1.92

4.29

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

101

2.48

4.29

1.2

1.3

109.3

87.8

1.20

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

407

1.71

4.28

1.1

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

261

1.89

4.25

2.7

2.2

48.8

43.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.88

4.25

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

508

1.63

4.23

1.2

1.3

u/ml

4.6

4.8

0.04

216

(3030981) Hyaline casts [#/volume] in Urine by Automated count

190

1399

1.38

4.21

3.1

2.6

e6/l

0.3

0.03

184

1351

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

146

2.20

4.20

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

146

2.20

4.20

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

146

2.20

4.20

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

146

2.20

4.20

2.0

—

(3052592) Norovirus Ag [Presence] in Stool

3.27

4.18

1.1

1.4

—

(3042631) Mycobacterium sp identified in Specimen

328

1.78

4.17

2.9

2.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.20

4.05

7.5

6.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

3.94

3.97

2.9

2.8

—

(3002619) Bacteria identified in Specimen by Culture

3.03

3.96

1.1

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

211

1.95

3.96

3.3

2.6

e6/l

380.4

582.2

2.38

177

(3029634) Reagin Ab [Titer] in Serum by VDRL

494

1.61

3.95

2.1

2.0

—

3.2

—

(3045424) Erythrocytes [Presence] in Urine

526

1.59

3.93

1.4

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

205

1.96

3.91

3.4

2.7

e9/l

0.2

0.20

177

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

575

1.56

3.89

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

220

1.92

3.86

1.1

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

120

2.26

3.80

3.7

7.4

mg/l

55.4

70.4

0.77

(40768443) Skin Pathology biopsy report

177

1312

1.37

3.79

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

269

2118

1.29

3.79

3.2

3.3

pmol/l

4.4

4.5

0.73

249

1896

(3006245) CD3-CD19+ cells/100 cells in Blood

114

2.29

3.77

2.5

2.0

10.1

11.8

0.33

109

(3000492) Spirometry study

393

3239

1.24

3.77

1.6

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

108

2.32

3.75

2.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

244

1.85

3.74

1.2

—

42.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

266

1.81

3.73

1.5

1.3

e6/l

4125.7

2533.5

0.38

193

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

223

1.89

3.72

1.1

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

159

1164

1.38

3.69

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

103

2.34

3.66

3.0

2.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

232

1.86

3.64

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.86

3.62

1.0

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

291

1.76

3.61

1.6

1.4

g/l

31.9

33.5

0.35

265

(3004616) Nuclear Ab [Presence] in Serum

397

1.65

3.60

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

191

1.95

3.57

1.6

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

644

1.50

3.57

2.6

2.4

ug/min

103.2

105.5

0.02

399

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

414

1.63

3.55

1.7

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

106

727

1.47

3.54

1.3

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

293

1.75

3.53

1.7

1.8

—

(3036489) Thrombin time

160

1183

1.37

3.51

2.4

2.1

21.3

0.06

142

1024

(3036525) Urea [Moles/time] in 24 hour Urine

6.16

3.50

3.8

3.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

481

1.57

3.43

5.7

5.4

umol/l

337.0

376.7

1.57

417

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

139

2.09

3.43

1.0

1.1

u/ml

3.7

8.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

211

1633

1.31

3.41

1.1

titre

208.6

139.8

0.23

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

319

1.70

3.40

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.35

3.40

4.6

5.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

105

725

1.46

3.40

1.7

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

107

2.25

3.38

1.0

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

579

1.51

3.37

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

756

0.58

3.34

1.5

—

(3019174) dRVVT (LA screen)

3.25

3.34

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

196

1.90

3.33

1.5

1.6

u/l

5.1

7.8

1.71

169

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.37

3.31

1.1

1.2

—

(3021901) Oxygen saturation in Capillary blood

470

1.56

3.29

3.3

2.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

204

1.87

3.29

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

285

1.73

3.28

3.8

3.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

221

1732

1.29

3.27

1.5

1.4

iu/l

25.4

28.7

0.69

193

1477

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

286

2315

1.25

3.25

2.3

2.4

au/ml

17.3

21.1

0.20

149

(21491868) Cryoglobulin [Mass/volume] in Serum

109

2.21

3.25

1.3

1.2

g/l

—

0.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

971

0.63

3.24

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

220

1.83

3.22

2.7

2.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

618

1.48

3.22

3.4

3.1

kpa

8.6

8.4

0.27

570

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

350

2900

1.23

3.22

3.8

4.0

ug/l

10.3

19.8

1.04

283

2290

(40768446) Kidney Pathology biopsy report

116

2.16

3.22

2.3

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

257

1.76

3.21

5.0

4.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

264

2122

1.26

3.19

1.3

au/ml

21.3

52.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.34

3.19

1.0

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

234

1855

1.28

3.17

1.3

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

631

1.47

3.11

5.5

2.0

nmol/l

0.8

0.14

532

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

194

1.86

3.10

1.4

u/l

368.7

355.8

0.04

188

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

128

1732

0.73

3.09

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

125

2.09

3.07

1.1

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

125

2.09

3.07

1.1

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.24

3.05

1.1

—

(3045788) Cell count panel - Pleural fluid

210

1.82

3.03

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

735

0.59

3.03

1.5

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

165

1257

1.33

3.02

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

126

2.07

3.02

1.8

1.3

2.8

4.8

—

(3005033) Fetal Nuchal fold Thickness US

733

0.60

3.00

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

156

1182

1.33

2.97

1.3

miu/ml

230.4

226.6

0.04

571

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

271

1.71

2.97

1.0

1.1

—

29.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

180

1393

1.31

2.96

2.1

2.2

u/l

6655.7

5642.5

0.17

548

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

647

1.45

2.94

1.7

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

388

1.58

2.93

2.3

2.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.15

2.93

1.3

1.0

—

(3045716) Anion gap in Serum or Plasma

121

2.07

2.92

2.2

2.4

mmol/l

8.8

9.7

0.37

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3279

31978

1.16

2.90

4.5

4.1

mmol/l

4.7

4.8

5.09

3083

29994

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.37

2.89

1.8

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.37

2.89

1.8

2.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

115

2.09

2.88

1.0

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.51

2.87

1.1

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

2.93

2.85

8.2

3.0

ml/dl

14.4

15.1

0.34

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3150

30643

1.15

2.84

4.0

3.7

mmol/l

1.3

1.91

2938

28453

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

109

2.12

2.84

1.6

2.0

mg/l

8.8

9.7

0.34

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

688

1.42

2.79

1.3

u/ml

276.0

261.2

0.18

414

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

442

1.52

2.77

1.6

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

418

1.54

2.77

1.3

1.2

u/ml

90.7

48.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

117

2.06

2.76

2.2

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

117

2.06

2.76

2.2

2.1

—

(3036180) Methadone [Presence] in Urine

8.34

2.75

2.6

3.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

233

1.72

2.71

1.5

1.3

e6/l

30080.3

67482.8

0.70

133

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

118

2.04

2.71

2.2

2.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

6.01

2.70

1.7

4.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

139

1.95

2.69

1.8

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.98

2.69

1.3

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

105

2.10

2.68

10.1

12.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.18

2.66

2.2

2.1

e6/l

5522.2

27718.5

0.55

(3048879) Bone marrow aspiration report

2.33

2.65

1.5

2.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.90

2.58

1.4

1.3

mmol/l

0.4

2.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

149

1.89

2.55

1.4

1.2

u/l

13.3

12.5

0.12

137

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.36

2.55

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

121

1.99

2.55

1.3

1.2

g/l

0.3

0.83

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

121

1.99

2.55

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

128

1.96

2.55

1.0

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.73

2.54

1.3

mmol/l

1.0

1.9

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

3.47

2.48

1.0

1.2

—

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

754

6806

1.13

2.46

1.6

1.5

—

(3004451) EKG impression Narrative

123

1.96

2.45

1.3

—

(3028433) Virus identified in Specimen by Culture

2.14

2.44

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

2.95

2.41

1.1

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

2.29

2.41

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.29

2.41

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.29

2.41

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.29

2.41

1.3

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

138

1.89

2.40

1.8

1.6

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

6.26

2.37

8.0

5.1

—

(3024263) Appearance of Synovial fluid

146

1.86

2.37

2.1

2.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.64

2.36

3.8

2.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

161

1.81

2.35

4.5

5.9

u/ml

42.8

216.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

134

1033

1.31

2.33

3.0

3.6

u/ml

242.5

1682.0

0.83

109

872

(3039443) Prostate specific Ag panel - Serum or Plasma

550

0.60

2.33

1.6

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3250

31781

1.14

2.32

4.4

4.1

mmol/l

1.5

0.42

3045

29674

(3024891) Influenza virus A+B Ag [Presence] in Specimen

117

886

1.33

2.31

1.1

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

285

1.59

2.27

2.0

1.8

ug/l

19.0

20.8

0.28

280

(3045142) Bone marrow Pathology biopsy report

317

1.55

2.27

1.5

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.07

2.26

1.2

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

127

1.90

2.25

1.9

1.8

—

(3017569) Oxygen content in Arterial blood

120

1.92

2.25

3.8

2.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

263

1.60

2.23

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

524

1.42

2.21

1.2

u/ml

4.4

4.2

0.03

178

(3013336) Amino acids [Identifier] in Serum or Plasma

5.56

2.21

1.4

5.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

264

1.60

2.20

1.0

1.1

—

(4306422)

517

1.42

2.19

1.3

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.50

2.18

1.2

—

(3049717) Cytology report of Urine Cyto stain

118

904

1.31

2.17

2.6

2.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

158

1.78

2.17

1.8

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

188

1.71

2.16

1.1

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.29

2.15

1.8

3.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.30

2.14

1.7

1.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

266

1.59

2.14

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3311

32452

1.14

2.14

4.9

4.5

mmol/l

2.7

2.8

8.55

3088

30248

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

895

0.70

2.13

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

895

0.70

2.13

1.5

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

137

1.83

2.13

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

894

0.70

2.12

1.5

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

267

1.58

2.11

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

339

1.51

2.11

1.1

1.2

—

(4024509)

275

1.57

2.11

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

123

1.88

2.11

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.21

2.10

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

891

0.70

2.09

1.5

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

229

1.62

2.08

1.8

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

5.00

2.07

1.4

1.1

nmol/l

725.5

603.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

207

1.65

2.04

1.1

ratio

1.1

1.0

0.57

(3040151) Glucose [Moles/volume] in Capillary blood

302

1.53

2.03

12.6

4.7

mmol/l

8.7

7.2

0.70

257

(3032057) Clostridioides difficile [Presence] in Stool

2.40

2.02

1.5

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

208

1.64

2.00

1.7

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

263

1.56

2.00

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.34

1.96

1.4

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

667

1.34

1.94

1.6

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.73

1.93

1.1

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.45

1.93

1.1

1.9

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

266

1.55

1.92

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.06

1.90

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

2.25

1.90

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

204

1.62

1.88

8.0

2.0

—

(3035880) pH of Pleural fluid

121

1.82

1.88

1.6

1.3

—

(4035726)

310

2685

1.17

1.85

1.6

1.4

—

(21494755) Public health laboratory ask at order entry panel

329

3766

0.86

1.84

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

4.17

1.82

1.0

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

368

1.45

1.81

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

145

1.73

1.81

1.9

2.2

ug/min

8.4

188.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.05

1.80

3.3

5.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

152

1237

1.24

1.78

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

241

2056

1.18

1.74

2.1

1.9

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

1.74

1.0

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

439

1.40

1.73

1.0

1.1

g/l

1.6

1.5

1.10

395

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

125

1.76

1.71

1.1

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.85

1.71

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

491

1.37

1.71

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.30

1.70

1.9

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

226

1.55

1.70

1.5

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

155

1272

1.23

1.69

2.1

1.9

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.00

1.69

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.00

1.69

1.1

103.0

94.9

0.50

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

215

1822

1.19

1.69

2.6

3.2

u/ml

36.1

50.7

1.13

201

1759

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

124

996

1.25

1.65

1.4

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.89

1.65

1.1

1.4

—

(4268621)

360

1.42

1.63

2.2

2.3

—

(3000034) Microalbumin [Mass/volume] in Urine

278

1.48

1.61

2.7

3.0

mg/l

47.3

51.3

0.05

201

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

770

7127

1.10

1.60

4.5

4.3

ug/l

2.2

2.3

0.20

692

6454

(3025018) Bordetella pertussis Ab [Titer] in Serum

198

1.57

1.59

1.2

—

(4146454)

288

1.46

1.57

3.4

2.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

129

1.71

1.56

2.2

1.5

umol/l

30.0

29.7

0.04

124

(3051387) C reactive protein [Mass/volume] in Capillary blood

647

0.71

1.55

5.5

3.3

mg/l

19.0

25.1

1.30

404

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

117

942

1.25

1.54

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

458

1.36

1.54

1.1

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

640

5885

1.10

1.52

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

108

1.76

1.50

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.81

1.47

1.0

1.2

—

(3003338) MCHC [Mass/volume]

2903

28413

1.09

1.45

26.8

15.6

g/l

332.1

332.7

3.07

2884

28214

(3002256) Pathology report gross observation

442

3995

1.12

1.45

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

559

1.31

1.44

2.2

3.6

u/ml

214.8

818.7

0.70

517

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.88

1.44

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

718

1.27

1.44

1.4

1.3

mmol/l

3.9

3.7

0.72

676

(3042951) Complement C1q Ab [Units/volume] in Serum

3.13

1.44

1.0

1.1

—

24.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

212

1.51

1.43

1.1

iu/ml

8.6

10.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

482

1.33

1.42

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

345

1.40

1.42

1.6

1.4

—

(1002224) Polysomnography panel

177

1503

1.19

1.40

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

157

1.60

1.40

1.0

1.4

—

67.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

501

1.32

1.40

1.2

1.1

125.0

117.1

1.27

458

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

291

2572

1.14

1.38

2.2

2.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.61

1.36

1.0

—

(40768806) Pleura Pathology biopsy report

231

1.48

1.36

1.7

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.94

1.36

7.6

4.7

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.94

1.36

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.94

1.36

1.0

—

(4212803)

2.94

1.36

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

223

1.48

1.35

1.5

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

101

817

1.24

1.32

1.5

1.4

mg/l

430.3

518.5

2.24

776

(3006922) Hepatitis E virus Ab [Presence] in Serum

233

1.46

1.31

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

533

1.30

1.31

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

129

1.63

1.29

1.7

2.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

318

1.39

1.29

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

447

1.32

1.29

1.4

1.3

mmol/l

6.7

7.3

1.19

330

(3000330) Specific gravity of Urine by Test strip

167

1424

1.18

1.28

3.4

3.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

218

1.47

1.28

1.1

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.00

1.27

2.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.29

1.26

1.3

1.2

—

(3000012) Reticulocyte production index

130

1.62

1.26

1.4

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

757

0.76

1.26

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

217

0.55

1.26

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

123

1.63

1.23

2.0

2.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

373

1.34

1.22

1.2

1.1

101.6

96.2

0.94

354

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

2.63

1.21

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

201

0.55

1.20

4.0

1.7

—

(3051651) Icteric interference index of Serum or Plasma

172

1.52

1.20

2.9

3.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.75

1.18

1.5

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

189

1.48

1.18

1.6

1.3

umol/l

22.7

26.6

0.28

178

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

318

1.36

1.12

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

217

1.43

1.11

1.1

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.38

1.09

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.76

1.06

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.65

1.06

1.4

2.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

578

1.25

1.06

1.1

au/ml

29.5

12.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

175

2000

0.87

1.05

1.9

1.7

—

(40768793) Breast Pathology biopsy report

769

0.79

1.05

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

137

1.54

1.05

1.0

1.1

iu/ml

147.9

191.0

0.60

137

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.96

1.03

1.7

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.64

1.03

1.3

1.6

ug/l

10.3

8.6

0.42

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.06

1.02

1.1

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

350

1.32

1.02

2.5

3.2

nmol/l

8.2

21.9

0.42

340

(1617658) Protocol used for examination of sentinel lymph nodes

275

0.65

1.01

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

2.00

1.00

2.1

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

172

1.46

0.99

1.2

1.3

nmol/l

133.0

134.4

0.06

172

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.84

0.98

1.4

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

148

1284

1.16

0.98

1.8

1.6

mu/l

368.0

300.9

0.89

136

1164

(3033705) Calcium.ionized [Moles/volume] in Venous blood

292

1.34

0.97

2.4

2.3

—

(3003694) ABO and Rh group [Type] in Blood

964

9186

1.07

0.97

1.4

1.5

—

(3006462) Nitrate [Presence] in Urine

140

1.50

0.97

3.0

3.1

—

(3035285) Chloride [Moles/volume] in Venous blood

301

1.33

0.97

2.4

2.3

mmol/l

104.8

105.6

0.44

295

(3041354) Potassium [Moles/volume] in Venous blood

301

1.33

0.97

2.4

2.3

mmol/l

4.1

4.0

0.79

295

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

165

1.46

0.96

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

116

1.55

0.96

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

207

1843

1.13

0.95

1.1

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.77

0.94

1.7

2.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

386

4182

0.91

0.93

2.7

2.8

ug/l

0.7

0.14

243

2554

(21494434) Karyotype in Bone marrow

234

1.37

0.93

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

397

0.73

0.93

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

843

0.82

0.93

1.4

1.5

—

(40757373) Influenza virus identified in Isolate

1.82

0.92

1.1

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.91

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

291

2650

1.11

0.91

5.6

3.7

—

(3022689) Creatine [Moles/volume] in Urine

1.60

0.90

1.2

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

429

1.26

0.90

3.6

3.1

nmol/l

0.9

0.8

0.58

327

(3008037) Lactate [Moles/volume] in Venous blood

546

1.23

0.89

4.1

2.8

mmol/l

1.4

1.5

0.41

528

(3028717) Thiamine [Mass/volume] in Blood

2.07

0.89

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.07

0.89

1.8

2.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

711

1.20

0.88

1.7

1.4

e6/l

5.9

27.3

1.67

549

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.65

0.88

1.6

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

712

1.20

0.87

1.7

1.5

e6/l

648.1

1460.9

0.65

579

(3044007) Cell count panel - Peritoneal fluid

1.61

0.87

2.6

2.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.00

0.87

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

265

1.32

0.84

1.1

mg/l

208.4

275.9

2.28

235

(3016750) Collection duration of Urine

171

1.41

0.83

2.7

2.1

min

525.1

495.6

1.18

130

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.88

0.81

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.88

0.81

4.7

2.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

223

1.35

0.81

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

384

3565

1.09

0.81

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

293

1.30

0.81

1.6

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

545

1.21

0.80

1.7

1.4

nmol/l

0.3

0.4

1.86

423

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

277

1.30

0.78

1.1

1.2

mg/l

23.7

41.3

6.01

240

(4211845)

156

1.41

0.78

2.9

3.0

—

(3004775) Volume in Urine collected for unspecified duration

216

1.35

0.78

2.6

2.2

639.9

628.4

0.06

148

(4034850)

1018

0.85

0.77

16.0

8.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.77

0.76

1.8

2.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.76

0.0

1.1

—

43.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

221

0.68

0.75

1.3

1.1

—

(44813793)

245

1.31

0.73

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

100

1.50

0.72

4.8

3.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.67

0.72

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.67

0.72

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.67

0.72

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

1.58

0.71

1.8

1.5

56.9

59.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.75

0.71

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.92

0.70

2.8

1.8

umol/l

42.2

44.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.92

0.70

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

283

1.27

0.69

1.2

1.4

—

(3033799) Differential panel - Peritoneal fluid

1.51

0.69

2.0

2.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.85

0.68

1.0

1.1

—

(4015189)

1.64

0.68

3.5

2.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

119

1.43

0.66

3.5

2.3

ug/l

1.5

1.3

0.27

107

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.59

0.65

1.1

1.8

pmol/l

63.8

31.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.59

0.65

1.0

2.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.73

0.64

1.0

1.1

—

24.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

109

964

1.13

0.62

1.9

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.63

0.62

1.3

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

517

1.18

0.61

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

130

1.39

0.61

3.9

2.3

—

(40768441) Liver Pathology biopsy report

253

1.27

0.61

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

105

1.43

0.60

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.51

0.58

1.1

2.0

mmol/l

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

511

1.18

0.58

4.5

2.9

mmol/l

7.4

7.3

0.07

497

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

123

1.38

0.57

1.1

1.0

—

(3034426) Prothrombin time (PT)

124

1.37

0.55

1.4

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

107

1.40

0.55

1.1

u/ml

0.3

1.9

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

143

1.33

0.52

1.4

2.3

ug/l

13.7

77.4

0.58

124

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

132

0.68

0.51

1.0

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

287

1.22

0.51

1.2

1.4

—

(40768800) Prostate Pathology biopsy report

391

0.82

0.51

1.3

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.46

0.50

3.0

1.6

—

(3017509) Phencyclidine [Presence] in Urine

1.46

0.50

1.5

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

289

1.21

0.48

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

107

0.65

0.48

3.6

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

107

0.65

0.48

7.1

5.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.49

0.47

1.1

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.49

0.47

1.0

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

176

0.74

0.46

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

103

1.36

0.45

1.4

1.6

—

(4281824)

352

0.82

0.45

1.3

1.1

—

(3025130) Human papilloma virus identified in Specimen

497

1.15

0.44

1.9

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

667

1.13

0.44

1.1

u/ml

5.5

5.9

0.06

343

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.61

0.43

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

131

1.30

0.42

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

399

3815

1.05

0.42

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

176

1.25

0.41

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.43

0.41

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

595

1.13

0.41

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

596

1.13

0.40

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.47

0.40

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.47

0.40

2.2

2.8

u/field

0.0

0.6

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(4133840)

1.36

0.40

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.31

0.39

5.1

7.8

—

(3029075) Extractable nuclear Ab panel - Serum

1.34

0.39

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.36

0.38

4.9

7.6

—

(3023410) Appearance of Cerebral spinal fluid

326

1.17

0.38

2.1

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

197

1.22

0.37

1.3

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

179

1.23

0.37

2.1

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

793

1.10

0.36

1.3

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

162

1.24

0.35

1.1

miu/ml

1301.1

1521.9

0.48

162

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

659

0.89

0.35

1.3

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.36

0.34

3.2

1.8

ng/l

96.1

102.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

586

5687

1.04

0.33

3.9

3.8

23.0

21.4

1.06

259

2501

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

350

1.14

0.32

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

530

1.11

0.32

1.1

iu/ml

78.3

1046.8

0.51

131

(3024869) Neuronal Ab [Presence] in Serum

1.28

0.32

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

103

1112

0.92

0.32

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

239

1.17

0.31

1.2

—

(3020491) Glucose [Moles/volume] in Blood

239

1.17

0.31

1.5

1.9

mmol/l

7.2

6.7

0.40

160

(3008401) Mugwort IgE Ab [Units/volume] in Serum

647

1.10

0.31

1.0

1.1

u/ml

1.1

1.4

0.12

269

(3038177) Helicobacter pylori Ab [Presence] in Serum

571

1.11

0.30

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

438

1.12

0.30

1.3

1.4

ug/l

2.5

3.9

1.28

389

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.33

0.30

2.1

1.9

umol/l

12.8

17.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

524

1.11

0.30

1.1

u/ml

16.1

2.9

0.65

253

(4027681)

203

1.18

0.29

1.3

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.25

0.29

1.4

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

142

1338

1.06

0.28

1.4

1.7

mg/l

3.7

0.02

105

929

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

237

0.84

0.27

28.4

18.4

nmol/l

1217.3

1492.0

1.10

232

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

261

1.15

0.27

1.1

—

(3015183) Erythrocyte sedimentation rate

204

0.83

0.26

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

234

0.85

0.24

19.0

13.6

nmol/l

691.6

847.1

1.02

226

(3041806) Other cells [#/volume] in Blood by Manual count

142

1.20

0.24

1.2

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.24

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

350

1.12

0.24

1.1

—

85.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

427

1.10

0.23

1.9

2.2

umol/l

10.5

5.6

0.44

312

(3006270) Folate [Moles/volume] in Blood

237

1.14

0.23

1.3

1.1

nmol/l

348.5

389.8

0.49

216

(3020874) Milk IgE Ab [Units/volume] in Serum

228

1.14

0.22

1.0

u/ml

0.3

3.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

247

1.13

0.22

1.5

1.6

mmol/l

7.4

7.7

0.26

151

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

365

3755

0.97

0.22

1.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.22

0.22

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.22

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(44806071)

1.16

0.21

1.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.16

0.21

1.2

u/ml

0.0

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

4.6

—

2.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

198

0.86

0.20

1.1

u/l

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.25

0.20

1.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

108

1.20

0.20

1.0

—

(4094501)

870

0.94

0.19

1.1

—

(40765096) Chromosome analysis panel by Banding

1.22

0.19

1.2

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.13

0.18

1.8

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

492

1.08

0.18

1.0

1.1

u/ml

3.9

4.3

0.05

193

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

446

1.08

0.17

1.2

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.20

0.16

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.11

0.16

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

182

0.88

0.15

1.1

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

1.18

0.15

1.0

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

752

1.05

0.14

1.1

u/ml

0.9

1.5

0.61

297

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

520

1.06

0.13

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

501

1.06

0.12

1.6

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

629

1.05

0.12

1.0

1.1

u/ml

2.1

2.4

0.09

145

(40768795) Lymph node Pathology biopsy report

312

0.93

0.11

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.10

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

279

0.93

0.09

1.3

mmol/l

11.3

11.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.09

0.09

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

239

2432

0.98

0.09

1.2

iu/ml

118.0

151.4

0.84

927

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.07

0.08

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

224

2203

1.02

0.08

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.85

0.07

1.9

3.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.11

0.05

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.10

0.04

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.10

0.04

1.3

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

368

1.03

0.04

1.1

—

4.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

229

0.96

0.02

1.0

u/ml

0.5

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

540

0.98

0.02

1.1

u/ml

6.7

3.9

0.34

197

(3009871) Measles virus Ab [Titer] in Serum

107

0.93

0.02

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

848

0.99

0.01

1.8

1.9

iu/l

5.7

4.9

0.20

319

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

128

1273

1.01

0.00

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

156

0.96

0.00

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

336

0.98

0.00

4.4

4.8

u/ml

79.2

79.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

454

1.01

0.00

1.0

1.1

u/ml

1.7

0.3

0.39

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

105

1.05

0.00

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

262

0.99

0.00

1.7

1.4

pmol/l

101.5

178.3

0.28

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

175

0.97

0.00

1.6

1.4

mmol/l

5.6

5.8

0.30

167

(1761482) Bacteria [#/volume] in Urine by Culture

642

1.00

0.00

4.6

4.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

141

0.99

0.00

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

254

0.98

0.00

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

326

1.01

0.00

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

156

1.03

0.00

1.9

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

226

1.02

0.00

1.6

2.2

u/field

3.0

1.7

0.33

101

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

216

1.02

0.00

6.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

267

1.01

0.00

1.2

titre

70.0

225.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

263

0.99

0.00

1.3

1.5

umol/l

12.4

12.1

0.11

248

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.03

0.00

1.7

1.1

—

16.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

133

0.98

0.00

1.5

3.5

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.8

—

4.3

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

5.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.02

0.00

1.3

1.1

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.97

0.00

3.1

1.8

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

7.3

—

124.9

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1308.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

65.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.01

0.00

1.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

115.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.96

0.00

1.2

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.3

—

8.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

2.6

—

(3022670) pH of Venous cord blood

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_BONECONTINUITY and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_BONECONTINUITY	2.042 [1.83, 2.28]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.147

During the follow-up period (1.1.1998 — 31.12.2019), 2291 out of 12198 females with M13_BONECONTINUITY died.

Males

Parameter	HR [95% CI]	p-value
M13_BONECONTINUITY	2.355 [2.08, 2.67]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1893 out of 11005 males with M13_BONECONTINUITY died.

Mortality risk

Mortality risk for people of age

years, who have M13_BONECONTINUITY.

N-year risk	Females	Males
1	0.186%	0.42%
5	1.185%	2.56%
10	2.745%	6.277%
15	5.261%	10.91%
20	9.063%	17.796%

Relationships between endpoints

↥

Index endpoint: M13_BONECONTINUITY – Disorders of continuity of bone

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of continuity of bone

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints